Stay updated on Midostaurin Combo with Chemo in FLT3 AML Clinical Trial

Sign up to get notified when there's something new on the Midostaurin Combo with Chemo in FLT3 AML Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Midostaurin Combo with Chemo in FLT3 AML Clinical Trial page

  1. Check
    6 days ago
    No Change Detected
  2. Check
    13 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.15.0 to version 2.15.2, indicating a revision in the content.
    Difference
    0.0%
    Check dated 2025-04-25T21:46:09.000Z thumbnail image
  3. Check
    20 days ago
    Change Detected
    Summary
    The web page has undergone significant content removal, particularly regarding the detailed description of a Phase IIIb study on midostaurin for treating FLT3-mutated Acute Myeloid Leukemia, including study design, endpoints, and inclusion/exclusion criteria. Additionally, the revision number has been updated from v2.14.4 to v2.15.0.
    Difference
    37%
    Check dated 2025-04-18T15:35:47.000Z thumbnail image
  4. Check
    28 days ago
    Change Detected
    Difference
    0.2%
    Check dated 2025-04-11T11:41:16.000Z thumbnail image
  5. Check
    35 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.14.3 to version 2.14.4.
    Difference
    0.0%
    Check dated 2025-04-03T22:13:53.000Z thumbnail image
  6. Check
    43 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.14.2 to version 2.14.3.
    Difference
    0.2%
    Check dated 2025-03-27T15:22:29.000Z thumbnail image
  7. Check
    50 days ago
    Change Detected
    Difference
    0.2%
    Check dated 2025-03-20T11:40:45.000Z thumbnail image

Stay in the know with updates to Midostaurin Combo with Chemo in FLT3 AML Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Midostaurin Combo with Chemo in FLT3 AML Clinical Trial page.